tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
US Market

Ascentage Pharma Group International Unsponsored ADR (AAPG) Ratios

Compare
22 Followers

Ascentage Pharma Group International Unsponsored ADR Ratios

AAPG's free cash flow for Q2 2025 was ¥0.91. For the 2025 fiscal year, AAPG's free cash flow was decreased by ¥ and operating cash flow was ¥-2.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.54 1.26 1.44 12.91 0.82
Quick Ratio
1.53 1.26 1.42 12.84 0.82
Cash Ratio
1.34 1.06 1.14 11.64 4.73
Solvency Ratio
-0.46 -0.13 -0.34 -0.36 -0.46
Operating Cash Flow Ratio
0.20 -0.10 -0.78 -5.16 -1.67
Short-Term Operating Cash Flow Coverage
0.30 -0.14 -1.20 -8.77 -15.19
Net Current Asset Value
¥ -461.51M¥ -869.49M¥ -1.09B¥ -785.12M¥ 179.96M
Leverage Ratios
Debt-to-Assets Ratio
0.56 0.64 0.72 0.63 0.37
Debt-to-Equity Ratio
2.58 6.32 29.72 4.39 0.88
Debt-to-Capital Ratio
0.72 0.86 0.97 0.81 0.47
Long-Term Debt-to-Capital Ratio
0.57 0.77 0.95 0.76 0.45
Financial Leverage Ratio
4.57 9.91 41.39 6.93 2.38
Debt Service Coverage Ratio
-1.29 -0.30 -1.05 -6.02 -13.04
Interest Coverage Ratio
0.00 -5.74 -9.08 -16.10 -51.99
Debt to Market Cap
0.11 0.04 0.20 0.17 0.15
Interest Debt Per Share
5.03 5.74 26.80 28.00 17.30
Net Debt to EBITDA
-0.05 -1.82 -0.98 -0.40 0.78
Profitability Margins
Gross Profit Margin
90.87%97.03%86.24%89.51%568.03%
EBIT Margin
-286.93%-33.73%-376.97%-397.87%-18844.74%
EBITDA Margin
-266.89%-24.23%-334.98%-367.87%-18190.20%
Operating Profit Margin
-286.93%-37.70%-393.11%-405.23%-20099.89%
Pretax Profit Margin
-292.74%-40.31%-420.24%-423.05%-19231.36%
Net Profit Margin
-296.77%-41.34%-416.98%-421.02%-18080.02%
Continuous Operations Profit Margin
-296.81%-41.37%-417.02%-421.02%-18080.02%
Net Income Per EBT
101.38%102.58%99.23%99.52%94.01%
EBT Per EBIT
102.02%106.90%106.90%104.40%95.68%
Return on Assets (ROA)
-38.05%-15.49%-37.02%-31.20%-26.61%
Return on Equity (ROE)
-249.24%-153.46%-1532.08%-216.05%-63.37%
Return on Capital Employed (ROCE)
-62.03%-25.48%-55.72%-43.60%-33.73%
Return on Invested Capital (ROIC)
-42.44%-16.58%-39.67%-34.28%-31.11%
Return on Tangible Assets
-39.29%-16.11%-38.73%-32.45%-27.41%
Earnings Yield
-2.10%-1.06%-10.63%-11.17%-11.13%
Efficiency Ratios
Receivables Turnover
4.98 9.90 1.36 3.41 0.08
Payables Turnover
0.30 0.32 0.42 0.23 0.05
Inventory Turnover
4.15 4.41 1.89 2.33 5.40
Fixed Asset Turnover
0.45 1.08 0.23 0.32 <0.01
Asset Turnover
0.13 0.37 0.09 0.07 <0.01
Working Capital Turnover Ratio
0.80 2.73 0.23 0.29 0.01
Cash Conversion Cycle
-1.05K -1.03K -403.64 -1.32K -6.63K
Days of Sales Outstanding
73.23 36.88 268.90 107.02 707.86
Days of Inventory Outstanding
87.89 82.79 193.20 156.77 431.02
Days of Payables Outstanding
1.21K 1.15K 865.74 1.59K 7.77K
Operating Cycle
161.12 119.66 462.10 263.79 1.14K
Cash Flow Ratios
Operating Cash Flow Per Share
0.71 -0.37 -10.29 -9.92 -9.50
Free Cash Flow Per Share
0.69 -0.45 -11.09 -13.52 -16.36
CapEx Per Share
0.02 0.08 0.81 3.59 6.86
Free Cash Flow to Operating Cash Flow
0.97 1.22 1.08 1.36 1.72
Dividend Paid and CapEx Coverage Ratio
31.31 -4.58 -12.77 -2.76 -1.38
Capital Expenditure Coverage Ratio
31.31 -4.58 -12.77 -2.76 -1.38
Operating Cash Flow Coverage Ratio
0.14 -0.07 -0.40 -0.36 -0.56
Operating Cash Flow to Sales Ratio
0.62 -0.11 -3.27 -3.12 -139.73
Free Cash Flow Yield
1.56%-0.35%-8.99%-11.27%-14.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-47.65 -94.51 -9.40 -8.95 -8.98
Price-to-Sales (P/S) Ratio
38.50 39.07 39.22 37.68 1.62K
Price-to-Book (P/B) Ratio
82.94 145.04 144.09 19.34 5.69
Price-to-Free Cash Flow (P/FCF) Ratio
63.91 -282.48 -11.12 -8.87 -6.75
Price-to-Operating Cash Flow Ratio
227.28 -344.10 -11.99 -12.08 -11.62
Price-to-Earnings Growth (PEG) Ratio
0.26 1.05 4.50 -0.98 4.03
Price-to-Fair Value
82.94 145.04 144.09 19.34 5.69
Enterprise Value Multiple
-14.48 -163.07 -12.68 -10.65 -8.14
Enterprise Value
15.10B 38.75B 9.43B 8.22B 6.40B
EV to EBITDA
-14.49 -163.07 -12.68 -10.44 -8.02
EV to Sales
38.66 39.51 42.49 39.19 229.48
EV to Free Cash Flow
64.18 -285.67 -12.05 -9.23 -6.15
EV to Operating Cash Flow
62.13 -347.97 -12.99 -12.57 -10.59
Tangible Book Value Per Share
1.70 0.57 -0.56 4.55 18.06
Shareholders’ Equity Per Share
1.95 0.87 0.86 6.20 19.40
Tax and Other Ratios
Effective Tax Rate
-0.01 -0.03 <0.01 <0.01 0.06
Revenue Per Share
1.14 3.25 3.15 3.18 0.07
Net Income Per Share
-3.39 -1.34 -13.12 -13.39 -12.29
Tax Burden
1.01 1.03 0.99 1.00 0.94
Interest Burden
1.02 1.19 1.11 1.06 1.02
Research & Development to Revenue
2.64 0.97 3.18 3.54 27.46
SG&A to Revenue
0.51 0.19 0.82 0.81 5.14
Stock-Based Compensation to Revenue
0.10 0.02 0.14 0.11 1.68
Income Quality
-0.14 0.28 0.78 0.74 0.73
Currency in CNY